Hannah Joseph Hospital Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹7 Cr
QMarch 2025
Quarterly Results

In 2026, Hannah Joseph Hospital (HANNAH) reported revenue ₹0 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit Hannah Joseph Hospital screener.

HANNAH Quarterly Results — Revenue, Profit & EPS Highlights

Hannah Joseph Hospital latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore HANNAH stock price history to track price trends across different timeframes.

  • Revenue of ₹78 Cr in March 2025 (+0.0% vs March 2025, +21.9% vs March 2024)
  • Net Profit of ₹7 Cr in March 2025 (+0.0% vs March 2025, +75.0% vs March 2024)
  • EBITDA of ₹21 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 27.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹4.32 in March 2025 (+0.0% vs March 2025)

Hannah Joseph Hospital Quarterly Results — Revenue, EBITDA, Net Profit & EPS

HANNAH quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 78 64 55 58 - -
Net Profit (₹ Cr) 0 7 4 1 0 - -
EBITDA (₹ Cr) 0 21 18 17 18 - -
EPS (₹) 0.00 4.32 2.44 0.63 0.86 - -
Operating Margin (%) 0.0% 27.0% 29.0% 30.0% 31.0% - -

HANNAH Share Price Trend — 1-Year Movement Across Quarterly Results

Hannah Joseph Hospital 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with HANNAH fundamental valuation to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 9.0%
EBITDA Margin 26.9%
Operating Margin 27.0%
ROE (Annual) 13.5%

Balance Sheet Highlights

Total Assets ₹99 Cr
Total Equity ₹52 Cr
Current Assets ₹23 Cr
Current Liabilities ₹32 Cr

Cash Flow Analysis

Operating Cash Flow ₹19 Cr
Investing Cash Flow ₹-14 Cr
Financing Cash Flow ₹-3 Cr
Net Cash Flow ₹3 Cr

HANNAH vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Hannah Joseph Hospital latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹443,373.10 Cr 1863.2 14,875 3,125 +10.8% - 21.0% 143.3
Divis Laboratories
Sept 2025
₹178,235.60 Cr 6921.5 2,860 689 +7.1% - 24.1% 266.5
Torrent Pharmaceuti…
Sept 2025
₹145,389.39 Cr 4403.9 3,219 591 +11.3% - 18.4% 251.1
Cipla
Mar 2026
₹107,240.96 Cr 1436.7 6,612 543 -14.3% -4.0% 8.2% 209.1
Dr Reddys Laborator…
Mar 2026
₹105,607.38 Cr 1303.6 7,996 221 -12.5% -11.5% 2.8% 491.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores